A detailed history of Holocene Advisors, LP transactions in Penumbra Inc stock. As of the latest transaction made, Holocene Advisors, LP holds 40,621 shares of PEN stock, worth $9.49 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
40,621
Holding current value
$9.49 Million
% of portfolio
0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.64 - $210.12 $6.65 Million - $8.54 Million
40,621 New
40,621 $7.89 Million
Q2 2022

Aug 15, 2022

SELL
$116.09 - $227.33 $703,273 - $1.38 Million
-6,058 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$187.51 - $283.98 $158,633 - $240,247
846 Added 16.23%
6,058 $1.35 Million
Q4 2021

Feb 14, 2022

SELL
$238.08 - $288.0 $458,542 - $554,688
-1,926 Reduced 26.98%
5,212 $1.5 Million
Q3 2021

Nov 15, 2021

BUY
$250.72 - $291.24 $627,050 - $728,391
2,501 Added 53.94%
7,138 $1.9 Million
Q2 2021

Aug 16, 2021

BUY
$235.0 - $310.7 $1.09 Million - $1.44 Million
4,637 New
4,637 $1.27 Million
Q3 2020

Nov 16, 2020

SELL
$185.27 - $238.73 $838,902 - $1.08 Million
-4,528 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$153.32 - $191.72 $404,611 - $505,949
2,639 Added 139.7%
4,528 $810,000
Q1 2020

May 15, 2020

SELL
$124.34 - $193.76 $543,117 - $846,343
-4,368 Reduced 69.81%
1,889 $305,000
Q4 2019

Feb 14, 2020

BUY
$134.81 - $177.8 $74,145 - $97,790
550 Added 9.64%
6,257 $1.03 Million
Q3 2019

Nov 14, 2019

BUY
$131.82 - $183.4 $446,078 - $620,625
3,384 Added 145.67%
5,707 $768,000
Q2 2019

Aug 14, 2019

BUY
$124.65 - $167.39 $289,561 - $388,846
2,323 New
2,323 $372,000
Q1 2019

May 15, 2019

SELL
$115.84 - $160.31 $367,096 - $508,022
-3,169 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$113.42 - $156.48 $156,633 - $216,098
1,381 Added 77.24%
3,169 $387,000
Q3 2018

Nov 14, 2018

BUY
$121.55 - $156.8 $217,331 - $280,358
1,788 New
1,788 $268,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $8.85B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.